Abstract:Flucytosine, CAS #2022-85-7, crystallizes in the tetragonal space group P 41212 (#94) with a = 6.643768(27), c = 23.89009(10) Å, V = 1054.500(7) Å 3 , and Z = 8. In this work, the sample was obtained from the United States Pharmacopeial Convention (USP) Lot #R03100 and analyzed as-received. The room temperature (295 K) crystal structure was refined using synchrotron ( λ = 0.412826 Å) powder diffraction data and optimized using the density functional theory (DFT). When looking down the a -axis, the crystal structure consists of multiple ribbon-like structures stacked into columns. The powder X-ray diffraction pattern of the compound has been submitted to ICDD® for inclusion in the Powder Diffraction FileTM (PDF®). The agreement of the Rietveld-refined and DFT-optimized structures is good, with the largest difference in the external amine group with an overall root mean displacement of 0.056 Å. There is also evidence of unit cell expansion at higher temperatures, as the volume of the unit cell at 298 K was 1.6–1.9% greater than the two unit cells obtained at 150 K. A N–H⋯O hydrogen bond exists in the inter-ribbon region between the flucytosine molecules, resulting in a 3D hydrogen bond network.

Powder X-ray Diffraction of 1-(4-aminophenyl)-5,6-dihydro-3-(4-morpholinyl)-2(1h)-pyridinone, C15H19N3O2

Crystal Structure of 2-(1-benzyl-3-phenyl-1h-pyrazol-5-yl)-5-(4-nitrobenzylthio)-1,3,4-oxadiazole, C25H19N5O3S

Crystal Structure of 5-(4-pyridyl)pyrimidine–4,4′-bipyridine–1,3,5-benzenetriol–water (1:1:1:1), C25H23N5O4

X-ray Powder Diffraction Data for 5-Chloro-n-(4-(5,6-dihydro-3-(4-morpholinyl)-2-oxo-1(2h)-pyridinyl)phenyl)-pentanamide, C20H26ClN3O3

The crystal structure of 2-(2-((4,6-dimethoxypyrimidin-2-yl)oxy)phenyl)-4-(piperidin-1-yl)-5 H -chromeno[2,3- d ]pyrimidine, C 28 H 27 N 5 O 4

4-(2-Chloro-4-nitrophenoxy)-n-[2-(4,6-dimethoxypyrimidin-2-yloxy)benzyl]aniline

Crystal structure of 3-((5-methylpyridin-2-yl)amino)-1-phenylpropan-1-one, C 15 H 16 N 2 O

Crystal Structure of N-(1-Benzyl-2-Oxoindolin-3-Yl)-N-P-Tolylbenzofuran-2-Carboxamide, C31h24n2o3

Crystal Structure of (Z)-2-(4-((5-bromopentyl)oxy)benzylidene)-4,5,6-trimethoxybenzofuran-3(2h)-one, C23H25BrO6

Synthesis, Crystal Structure, And Theoretical Studies Of N-(4-((4-Chlorobenzyl)Oxy)Phenyl)-4-(Trifluoromethyl)Pyrimidin-2-Amine

Crystal structure of 2-(2,3-bis(4-methoxyphenyl)-1 H -pyrrolo[2,3- b ]quinoxalin-1-yl)anilin, C 30 H 24 N 4 O 2

The crystal structure of 2,3-di(pyridin-2-yl)-2,3-dihydroquinazolin-4(1 H )-one, C 18 H 14 N 4 O

X-ray Powder Diffraction Data for Thiamphenicol, C12H15Cl2NO5S

Crystal Structure of 2-(2-naphthyl)-4,6-dimethylpyrimidine, C16H14N2

The crystal structure of 3-(2,5-dimethylanilino)-1-(2,5-dimethylphenyl)-4-methyl-1 H -pyrrole-2,5-dione, C 21 H 22 N 2 O 2

X-ray Powder Diffraction Data for Bisacodyl, C22H19NO4

Powder X-ray diffraction of flucytosine, C4H4FN3O

Crystal structure of (2 S ,3 R ,4 S ,5 S ,6 R )-4,5-dihydroxy-6-(hydroxymethyl)-2-(((4 aS ,5 R ,6 S )-1-oxo-5-vinyl-4,4 a ,5,6-tetrahydro-1 H ,3 H -pyrano[3,4- c ]pyran-6-yl)oxy)tetrahydro-2 H -pyran-3-yl 2,3-dihydroxybenzoate hydrate, C 23 H 26 O 12 ·H 2 O

Crystal structure of 2,5-bis(2,5-dimethoxybenzyl)-3,6-dimethyl-2,5-dihydropyrrolo[3,4-c]pyrrole-1,4-dione, C 26 H 28 N 2 O 6

Crystal structure of ( Z )-4-((4,5,6-trimethoxy-3-oxobenzofuran-2(3 H )-ylidene)methyl)phenyl diphenylphosphinate, C 30 H 25 O 7 P

Crystal Structure of N-((Z)-amino(((E)-amino(phenylamino)methylene) Amino)methylene)benzenaminium Chloride – Benzo[f]isoquinolino[3,4-B][1,8]naphthyridine – Tetrahydrofurane (1/2/2), C60H54ClN11O2